Filter
2113
Text search:
controlled
drugs
Featured
Recommendations
251
New Publications
454
Language
Document type
No document type
1198
Guidelines
395
Studies & Reports
287
Manuals
121
Strategic & Response Plan
45
Fact sheets
29
Training Material
23
Situation Updates
6
Brochures
4
Resource Platforms
2
Infographics
2
Countries / Regions
India
137
Global
64
Kenya
55
South Africa
55
Uganda
41
Western and Central Europe
41
Ethiopia
36
Nigeria
34
Tanzania
33
Africa
30
Latin America and the Carribbean
29
Sierra Leone
28
Nepal
28
Malawi
28
Ukraine
27
Zambia
26
Eastern Europe
25
Philippines
22
Rwanda
22
Ghana
20
Liberia
19
Bangladesh
18
Myanmar / Burma
18
Zimbabwe
17
Russia
17
Syria
15
Indonesia
15
Asia
13
Brazil
12
Lesotho
12
South–East Asia Region
12
South Sudan
11
Namibia
11
Eswatini/ Swaziland
11
Mozambique
10
Colombia
9
Burkina Faso
8
Botswana
8
Congo, Democratic Republic of
7
Germany
7
East and Southern Africa
7
Venezuela
7
Guinea
6
Cameroon
6
Afghanistan
6
Yemen
6
Haiti
5
Lebanon
5
Thailand
5
Sudan
5
Tajikistan
5
Senegal
4
Jordan
4
West and Central Africa
4
Eastern Europe and Central Asia
4
North America
4
Mali
3
USA
3
Pakistan
3
Iraq
3
Cambodia
3
Central African Republic
3
Argentina
3
Angola
3
Madagascar
3
Middle East and North Africa
3
Paraguay
3
Iran
3
Georgia
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Somalia
2
Egypt
2
China
2
North Macedonia
2
Hungary
2
Ecuador
2
Libya
2
Mexico
2
Sri Lanka
2
Palestine
2
Albania
2
Canada
2
Lithuania
2
Kyrgyzstan
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
Turkey
1
Singapore
1
Papua New Guinea
1
Benin
1
Peru
1
Serbia
1
Burundi
1
Bolivia
1
Greece
1
Chile
1
Western Pacific Region
1
Bhutan
1
Poland
1
Djibouti
1
Armenia
1
Laos
1
Qatar
1
Moldova
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
691
Clinical Guidelines
288
Public Health
122
Women & Child Health
102
Key Resources
59
Pharmacy & Technologies
27
Capacity Building
22
Toolboxes
Mental Health
289
HIV
236
TB
173
COVID-19
97
NTDs
84
Pharmacy
81
NCDs
80
AMR
67
Caregiver
55
Ebola & Marburg
38
Malaria
37
Conflict
33
Refugee
25
Disability
22
Rapid Response
17
Planetary Health
17
Cholera
14
Global Health Education
14
Natural Hazards
12
Polio
7
Health Financing Toolbox
7
Zika
6
Specific Hazards
6
2.0 Rapid Response
3
Social Ethics
2
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Technical Brief
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation
...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amp
...
A practical toolkot
Accessed: 07.11.2019
Practical Guidance for collaborative interventions
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita
...
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexualit
...
The END TB Strategy
Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных наркотиков
PLOS ONE | https://doi.org/10.1371/journal.pone.0192068 March 9, 2018
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z